grant

Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings: the ETHOS III Study [ 3/1/2022 - 2/28/2027 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/2006282]

Brief description Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.

Funding Amount $1,349,604

Funding Scheme Partnership Projects

Chief Investigator Prof Jason Grebely

Notes Partnership Projects - 2nd call for 2020

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857